Information:
Error:
ID
18588
Description
A Randomized, Open-Label Study to Compare the Efficacy and Safety of AT1001 and Enzyme Replacement Therapy (ERT) in Patients With Fabry Disease and AT1001-Responsive GLA Mutations, Who Were Previously Treated With ERT Open Label Extension
Keywords
Versions (2)
- 11/2/16 11/2/16 -
- 11/11/16 11/11/16 -
Uploaded on
November 11, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Open Label Extension Galafold (migalastat) AT1001-012 NCT01218659
Open Label Extension Galafold (migalastat) AT1001-012 NCT01218659
Similar models
Open Label Extension Galafold (migalastat) AT1001-012 NCT01218659
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Date of visit
Item
Date of visit
date
C1320303 (UMLS CUI [1])
Item
Will the subject continue into Open Label Extension?
integer
C3640652 (UMLS CUI [1])
CL Item
Yes, the subject successfully completed Visit 9/Month 18 and will continue into open label extension. Please proceed to Visit 10/Month 24. (1)
CL Item
No, the subject successfully completed Visit 9/Month 18 but will not continue into open label extension. Please ensure subject completes Visit 14/Month 19 or 31. (2)
CL Item
No, the subject terminated and did not complete Visit 9/Month 18. Please ensure subject completes Visit 14/Month 19 or 31. (3)